-
ACLA White Paper: Considerations for Appropriate Use of SARS-CoV-2 Testing
-
ACLA Statement on Recent Steps to Expand Testing
Washington, D.C. – Following the announcement of new steps and updated CDC guidelines to ramp up testing and help schools reopen, ACLA President Julie Khani ... Read More -
ACLA Elects 2021-2022 Board of Directors
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2021-2022. William Morice II, M.D., Ph.D., ... Read More -
ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing
Washington, D.C. Following the Biden Administration’s new guidance on coverage requirements for COVID-19 testing, ACLA President Julie Khani released the following statement: “President Biden’s decisive ... Read More -
ACLA Letter To Senate Finance Committee On Xavier Becerra’s Nomination
-
ACLA Letter To Biden Administration On COVID Testing
-
ACLA Member Labs Surpass 100 Million COVID-19 Tests Performed
Association Outlines Key Priorities to Address Next Phase of the Pandemic WASHINGTON, D.C. – Members of the American Clinical Laboratory Association (ACLA) today surpassed 100 million ... Read More -
ACLA Letter to New York State on Executive Order
-
ACLA Statement on President Biden’s Actions to Combat COVID-19
Washington, D.C. – Following President Biden’s actions announced today to combat the COVID-19 pandemic, ACLA President Julie Khani released the following statement: “We commend President Biden ... Read More -
Joint Letter on Cycle-Threshold Value Reporting
